Unknown

Dataset Information

0

Fighting pathogenic yeasts with plant defensins and anti-fungal proteins from fungi.


ABSTRACT: Fungal infections represent a significant health risk worldwide. Opportunistic infections caused by yeasts, particularly by Candida spp. and their virulent emerging isolates, have become a major threat to humans, with an increase in fatal cases of infections attributed to the lack of effective anti-yeast therapies and the emergence of fungal resistance to the currently applied drugs. In this regard, the need for novel anti-fungal agents with modes of action different from those currently available is undeniable. Anti-microbial peptides (AMPs) are promising candidates for the development of novel anti-fungal biomolecules to be applied in clinic. A class of AMPs that is of particular interest is the small cysteine-rich proteins (CRPs). Among CRPs, plant defensins and anti-fungal proteins (AFPs) of fungal origin constitute two of the largest and most promising groups of CRPs showing anti-fungal properties, including activity against multi-resistant pathogenic yeasts. In this review, we update and compare the sequence, structure, and properties of plant defensins and AFPs with anti-yeast activity, along with their in vitro and in vivo potency. We focus on the current knowledge about their mechanism of action that may lead the way to new anti-fungals, as well as on the developments for their effective biotechnological production. KEY POINTS: • Plant defensins and fungal AFPs are alternative anti-yeast agents • Their multi-faceted mode of action makes occurrence of resistance rather improbable • Safe and cost-effective biofactories remain crucial for clinical application.

SUBMITTER: Manzanares P 

PROVIDER: S-EPMC10973029 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fighting pathogenic yeasts with plant defensins and anti-fungal proteins from fungi.

Manzanares Paloma P   Giner-Llorca Moisés M   Marcos Jose F JF   Garrigues Sandra S  

Applied microbiology and biotechnology 20240327 1


Fungal infections represent a significant health risk worldwide. Opportunistic infections caused by yeasts, particularly by Candida spp. and their virulent emerging isolates, have become a major threat to humans, with an increase in fatal cases of infections attributed to the lack of effective anti-yeast therapies and the emergence of fungal resistance to the currently applied drugs. In this regard, the need for novel anti-fungal agents with modes of action different from those currently availab  ...[more]

Similar Datasets

| S-EPMC8621364 | biostudies-literature
| S-EPMC8715435 | biostudies-literature
| S-SCDT-10_15252-EMBJ_2022112634 | biostudies-other
| S-EPMC7734056 | biostudies-literature
| S-EPMC9920077 | biostudies-literature
| S-EPMC4832473 | biostudies-other
2024-07-03 | PXD053628 |
| S-EPMC3051899 | biostudies-other
| S-EPMC9770985 | biostudies-literature
| S-EPMC10152141 | biostudies-literature